Xcout Intel
NanoBio Corp
NanoBio Corp. is a biopharmaceutical company based in Ann Arbor, Michigan, focused on developing dermatological products and anti-infective treatments.
Subscribe to see NanoBio Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
NanoBio Corp at a glance
NanoBio Corp is a biotechnology company headquartered in United States. It has raised at least $16.7M across the 5 funding rounds on record, 4 of them with a disclosed amount. Its most recent funding round raised $10M in May 2018. Xcout tracks 1 named person at NanoBio Corp, including Needa Brown (Principal Investigator).
NanoBio Corp leadership
- Needa BrownPrincipal Investigator
NanoBio Corp funding rounds
At least $16.7M raised across the 5 rounds on record (4 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $10M | 1 named | |
| SEC Form D filing | $775,000 | — | |
| SEC Form D filing | $1.8M | — | |
| Series B | $4.1M | — | |
| Seed | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
NanoBio Corp competitors
A few of NanoBio Corp's closest competitors — see the full list of competitors and alternatives →
BlueWillow Biologics, Inc. is a privately held clinical-stage biopharmaceutical company located in Ann Arbor, Michigan. The company specializes in the development of proprietary intranasal vaccines and immune-modulating technologies.
MDI Therapeutics, Inc. is a pharmaceutical company headquartered in Novi, Michigan. The company specializes in researching and developing novel therapeutics for the treatment of fibrosis and related fibrotic diseases.
NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses. For herpes-related conditions, it offers HerpeCide in multiple forms: dermal topical and eye drops to treat ailments such as shingles, postherpetic neuralgia (PHN), chickenpox, recurrent herpes labialis, genital herpes, and ocular herpes keratitis. An intraocular injectable version of HerpeCide is also under development for viral acute retinal necrosis. Another significant therapeutic candidate is FluCide, a broad-spectrum anti-influenza nanoviricide, designed for both hospitalized patients via injection and outpatients through an oral formulation. NanoViricides also develops specialized nanoviricide eye drops for viral diseases affecting the external eye, DengueCide for various strains of Dengue viruses, and HIVCide, an anti-HIV nanoviricide specifically engineered to resist viral escape. Furthermore, the company is actively advancing additional nanoviricide drug projects targeting a diverse range of viruses and indications, alongside expanding its HerpeCide program to encompass a broader spectrum of herpes viruses and associated conditions. NanoViricides, Inc. was established in 2005 and maintains its corporate headquarters in Shelton, Connecticut.
Micron Biomedical, Inc. is a clinical-stage biopharmaceutical and life science company committed to expanding global access to therapeutics and vaccines formulated into proprietary array-based delivery technologies.
AMR Bio is a clinical-stage biotechnology company headquartered in London, United Kingdom, focused on infection prevention and antimicrobial resistance. The company is dedicated to developing novel anti-infectives, including its Phase 3-ready, first-in-class topical antimicrobial candidate XF-73.
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company located in Mission Viejo, California, focused on developing a platform of compounds for biodefense and fibrosis applications.
Get NanoBio Corp's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on NanoBio Corp in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access